Lumos Diagnostics Holdings Limited announced that Doug Ward, an experienced commercial diagnostics executive, has been appointed to the CEO role and will commence with Lumos in mid-June following completion of his notice obligations to his current employer. Doug brings over 30 years of experience in the diagnostics and life sciences industries, and has held senior executive roles with leading, multinational healthcare companies including Roche /Ventana Medical, GE, Siemens, Bayer, Chiron and Hologic.
Lumos Diagnostics Holdings Limited
Equities
LDX
AU0000157091
Medical Equipment, Supplies & Distribution
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.039 AUD | 0.00% | -17.02% | -46.58% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-46.58% | 13.8M | |
-6.16% | 12.1B | |
-3.26% | 8.16B | |
+6.61% | 5.78B | |
+31.20% | 5.59B | |
-9.05% | 4.23B | |
-56.99% | 2.87B | |
+11.87% | 2.71B | |
-5.34% | 2.35B | |
+25.34% | 2.21B |
- Stock Market
- Equities
- LDX Stock
- News Lumos Diagnostics Holdings Limited
- Lumos Diagnostics Holdings Limited Appoints Doug Ward as CEO